Posted inNewsHong KongESGResearch

Hong Kong’s wealthy look for healthcare impact

However, in the SAR, sustainable investing is still all about returns.
Healthcare, medical, insurance fees or financial health check concept, stethoscope with pink piggy bank on wooden table.

Improvement in access to healthcare services and increased access to education are among the top metrics for measuring the impact of sustainable and responsible investments among Hong Kong’s wealthy, according to a survey conducted by BNP Paribas Wealth Management and Scorpio Partnership.

However, return on investments continues to be the top metric for Hong Kong investors, according to the survey that poled entrepreneurs globally who have a net worth average of $5.8m.

Top three metrics for measuring impact of responsible investments

Return on investment 55%
Improvement in access to healthcare services 50%
Increased access to education 50%
Source: BNP Paribas Wealth Management and Scorpio Partnership


The results are similar within Asia-Pacific as a whole, where investors consider investment returns and improvement in healthcare as the two most important measurements for impact.


Which of the following areas do you consider when measuring the impact of your sustainable and responsible investments?



Return on investment



Improvement in access to healthcare services



Reduction in carbon footprint



Improved diversity in the workforce



Increased access to education



Reduction in unemployment



Increased supply of microfinance loans



Improvement in literacy rate



Source: BNP Paribas Wealth and Scorpio Partnership

Thematic demand

The study noted that healthcare is also a predominant theme that Hong Kong and Asia-Pacific investors look at when investing in a particular sector.

Top themes Hong Kong investors like for growth potential over five years

Technology 54%
Pharmaceuticals and healthcare 35%
Financial services 31%
Infrastructure 30%
Sustainable and responsible investments 29%


Asia-Pacific and global averages

Global Asia-Pacific
Technology 62% 62%
Pharmaceuticals and healthcare 30% 37%
Financial services 33% 36%
SRI 30% 34%
Telecommunications and media 31% 31%
Infrastructure 28% 31%
Consumer goods 27% 31%
Logistics 23% 25%
Education 18% 25%
Passion / lifestyle investments 18% 17%
Source: BNP Paribas Wealth Management, Scorpio Partnership


Mario Knoepfel, UBS Wealth Management’s Hong Kong-based Asia-Pacific head of sustainable and impact investing for advisory, believes that the investment case for healthcare has been particularly strong in advancing healthcare access in emerging markets.

“China and India, in particular, have the highest growth rates in healthcare spending,” he told FSA.

He added that Apac investors would also like to see their healthcare investments support the development of new disease treatment.

One of the bank’s healthcare-focused SRI products has had interest in the region, according to Knoepfel.

For example, around half of the $471m raised for the Oncology Impact Fund launched in 2016, which invests in companies that develop cancer treatments, came from UBS’ Asia-Pacific clients.

According to Knoepfel, the fund made a donation of around $1.2m to the American Association of Cancer Research last year and has dedicated a second $1.2m to UBS’ Optimus Foundation to support emerging market access to cancer care.

Separately, Knoepfel said that Apac-sourced assets of the firm’s sustainable cross-asset portfolio, which was launched in Asia in April last year, grew to $600m in June from $400m in March.

Part of the Mark Allen Group.